Duchenne muscular dystrophy is characterized by a mutation in the DMD gene that leads to a lack of dystrophin and muscle loss ...

Rhode Island manufacturer’s latest environment monitoring solution recognized for exceptional simplicity, ease of use, and ...

Empatica, a pioneer in digital biomarker development and patient monitoring using wearables and AI, today unveiled ...

Vidhu Thaker, M.D., Pediatric Endocrinology, Columbia University, New York City will present a poster from the 14-week, multicenter, international, randomized, double-blind, placebo-controlled Phase 2 ...

The cumulative data from the Phase 1 study indicate that salanersen has a generally well tolerated safety profile at both the 40 mg and 80 mg doses, with most adverse events (AEs) mild to moderate in ...

The American Diabetes Association's McCormick Place event was also a bit of a coming out party for North Chicago-based Abbott's new head of diabetes business.

The UK has become the first country in the world to join a new global network of health regulators focused on the safe, effective use of artificial intelligence (AI) in healthcare.

The FDA searched international vaccine safety databases for small-fiber neuropathy, one of the most common symptoms he mentioned in a write-up of the patients, and found it was less prevalent in ...

A groundbreaking nurse-led study challenged accepted practice for providing oxygen to children on ventilators in intensive care.

After three and half years of intensive negotiations and 13 rounds of meetings the 78th World Health Assembly (WHA), the WHO’s peak decision-making body (comprising of all of 194 sovereign member ...

Revuforj (revumenib) is an oral, first-in-class, selective menin inhibitor that is FDA approved for the treatment of relapsed or refractory (R/R) acute leukemia with a lysine methyltransferase 2A gene ...